<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03386760</url>
  </required_header>
  <id_info>
    <org_study_id>17-PP-07</org_study_id>
    <nct_id>NCT03386760</nct_id>
  </id_info>
  <brief_title>Evaluation of an Ultra-speed Picosecond Laser for Treating Tattoos</brief_title>
  <acronym>PicoS</acronym>
  <official_title>Evaluation of an Ultra-speed Picosecond Laser for Treating Tattoos</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators developed an ultra-speed picosecond laser (20ps) with a 20gHz repetition
      rate that provide very promising results in vitro and in ex vivo skin to remove skin tattoos.

      The aim of this study is to evaluate the efficacy and tolerance of a new ultra-speed
      picosecond laser and to compare it to a nanosecond laser for treating black tattoos.

      In a first phase of the study 10 patients with black tattoos will be treated with increasing
      fluencies of the picosecond laser to the optimal parameters in terms of efficacy and
      tolerance.

      In a second phase, 10 additional subjects with black tattoos will be treated after central
      randomization on half of the tattoo with the picosecond laser (with the parameters determined
      in the first phase) and the other half treated with a nanosecond laser.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2018</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of decrease of tattoos 2 months after the third session as compared to baseline on standardized pictures</measure>
    <time_frame>2 month after the end of laser utilisation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of Pain with EVA test</measure>
    <time_frame>2 months after one session of laser utilisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of tolerance</measure>
    <time_frame>2 months after one session of laser utilisation</time_frame>
    <description>correlation between EVA test and dermatological clinical signs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>satisfaction evaluation of depigmanetation tattoo</measure>
    <time_frame>2 months after one session of laser utilisation</time_frame>
    <description>satisfaction tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin biopsies</measure>
    <time_frame>immediately after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Tattoo; Pigmentation</condition>
  <arm_group>
    <arm_group_label>A- Ultra-Speed Picosecond laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Utilisation of Ultra-speed Picosecond laser for tattoo depigmentation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B- Nanosecond laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Utilisation of Nanosecond laser for tattoo depigmentation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser Utilisation PicoSecond</intervention_name>
    <description>Laser utilisation for tattoo depigmentation
1 session every month for a total of 3 sessions</description>
    <arm_group_label>A- Ultra-Speed Picosecond laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser Utilisation Nano-second</intervention_name>
    <description>Laser utilisation for tattoo depigmentation
1 session every month for a total of 3 sessions</description>
    <arm_group_label>B- Nanosecond laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Black tattoos with surface between 10 and 100 cm²

          -  Skin type I to VI

        Exclusion Criteria:

          -  Childbearing age women

          -  Active dermatosis located on the tattoo

          -  Personal history of hypertrophic scars or keloids

          -  Pigmentary or vascular lesions located on the tattoo

          -  Subject taking oral steroid or retinoid or have any risk of delayed healing problems

          -  Acquired or hereditary conditions that could leead to a delayed healing

          -  Allergy to xylocaine, prilocaine or lidocaine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Thierry PASSERON, PhD</last_name>
    <phone>+33492036488</phone>
    <email>passeron.t@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nice - Dermatologie - Hôpital Archet</name>
      <address>
        <city>Nice</city>
        <zip>06200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry PASSERON, PhD</last_name>
      <phone>+33492036488</phone>
      <email>passeron.t@chu-nice.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2017</study_first_submitted>
  <study_first_submitted_qc>December 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2017</study_first_posted>
  <last_update_submitted>March 19, 2018</last_update_submitted>
  <last_update_submitted_qc>March 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tattoo</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

